Location: Chicago, IL
CIK: 0001274403 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $1.1B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PBLS | PARABILIS MEDICINES INC | 6,412,780 | $176M | 16.0% | — | — | COM | 698955101 |
| BEAM | BEAM THERAPEUTICS INC | 4,540,132 | $156M | 14.2% | — | — | COM | 07373V105 |
| RAPP | RAPPORT THERAPEUTICS INC | 3,728,738 | $155M | 14.1% | — | — | COM | 75383L102 |
| SPTX | SEAPORT THERAPEUTICS INC | 6,294,951 | $137M | 12.4% | — | — | COMMON STOCK | 81221K108 |
| ERAS | ERASCA INC | 7,091,557 | $130M | 11.8% | — | — | COM | 29479A108 |
| VIR | VIR BIOTECHNOLOGY INC | 12,694,163 | $129M | 11.8% | — | — | COM | 92764N102 |
| MAZE | MAZE THERAPEUTICS INC | 4,120,053 | $123M | 11.2% | — | — | COM | 578784100 |
| LYEL | LYELL IMMUNOPHARMA INC | 3,247,162 | $45.53M | 4.1% | — | — | COM NEW | 55083R203 |
| GENB | GENERATE BIOMEDICINES INC | 1,944,426 | $32.8M | 3.0% | — | — | COM SHS | 370920100 |
| TXG | 10X GENOMICS INC | 217,834 | $8.352M | 0.8% | — | — | CL A COM | 88025U109 |
| BOLD | BOUNDLESS BIO INC | 2,694,095 | $6.735M | 0.6% | — | — | COM | 10170A100 |
| GOSS | GOSSAMER BIO INC | 8,055,916 | $1.326M | 0.1% | — | — | COM | 38341P102 |